LACIN STANSBURY: Open Payments
NPI 1548625064 · NEDERLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 13 payments from 7 companies in 2025. Trend: 2023 $282 · 2024 $388 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $99 |
| PFIZER INC. | 3 | $80 |
| GENZYME CORPORATION | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| TOLMAR, INC. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: ELIQUIS, FARXIGA, AIRSUPRA, DUPIXENT, TRELEGY ELLIPTA, JATENZO, ZORYVE, The Cologuard Plus Collection Kit.
Industry payments across TX — which companies pay providers there.
